GlassScriptPhysician profile
Brian D Wellington
NPI 1336422955
$871.79
in general payments reported to CMS, 2019-2025
16 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.63 · 2020: $41.35 · 2021: $37.82 · 2022: $79.44 · 2023: $285 · 2024: $176 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $440.29 | 2023-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $189.37 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Dexcom, INC. | $38.71 | 2021-2022 | |
| Novo Nordisk INC | $28.77 | 2022-2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.71 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $19.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.88 | 2020 | |
| Pfizer INC. | $15.44 | 2023 | |
| Amgen INC. | $13.79 | 2022 | |
| Exact Sciences Corporation | $13.57 | 2025 | Cologuard Collection Kit |
| Endogastric Solutions, INC | $12.09 | 2023 | Esophyx |
| Teva Pharmaceuticals USA, INC. | $12.03 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.86 | 2019 | |
| Nevro Corp. | $11.78 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.63 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wellington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.